In one paragraphArticle in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
15 authors.
Lorenzo ChiaveriniDepartment of Pharmacy, University of Pisa, Via Bonanno Pisano 6, 56126 Pisa, Italy.ORCID 0000-0003-4857-9819 Davide PirodduDepartment of Chemical, Physical, Mathematical and Natural Sciences, University of Sassari, 07100 Sassari, Italy.
Matteo PaciniDepartment of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Savi 10, 56126 Pisa, Italy.
Riccardo Di LeoNational Council of Research (CNR), Institute of Clinical Physiology, 56124 Pisa, Italy.
Emma BagliniNational Council of Research (CNR), Institute of Clinical Physiology, 56124 Pisa, Italy.ORCID 0000-0002-8378-4052 Damiano CirriDepartment of Chemistry and Industrial Chemistry (DCCI), University of Pisa, Via G. Moruzzi, 13, 56124 Pisa, Italy.ORCID 0000-0001-9175-9562 Diego La MendolaDepartment of Pharmacy, University of Pisa, Via Bonanno Pisano 6, 56126 Pisa, Italy.ORCID 0000-0002-4193-7612 Alessandro PratesiDepartment of Chemistry and Industrial Chemistry (DCCI), University of Pisa, Via G. Moruzzi, 13, 56124 Pisa, Italy.ORCID 0000-0002-9553-9943 Andrea NicoliniDepartment of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Savi 10, 56126 Pisa, Italy.ORCID 0000-0002-5178-9510 Alessandro ZucchiDepartment of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Savi 10, 56126 Pisa, Italy.ORCID 0000-0003-2252-4297 Alessandro MarroneDepartment of Pharmacy, University "G d'Annunzio" Chieti-Pescara, Via dei Vestini 31, 66100 Chieti, Italy.ORCID 0000-0002-8311-8172 Iogann TolbatovDepartment of Chemical, Physical, Mathematical and Natural Sciences, University of Sassari, 07100 Sassari, Italy.ORCID 0000-0001-9700-5331 Funding
Ministero dell'università e della ricerca 2022ALJRPLUniversity of Pisa SPARK-2025
6 · The paper itselfAbstract
Platinum-based drugs play a pivotal role in contemporary cancer treatment, but their therapeutic utility is often limited by acquired resistance. The diiodido analog, cis-[PtI
Indexed as
AmmoniaAntineoplastic AgentsChloridesIodidesOrganoplatinum CompoundsCisplatinDensity Functional TheoryHalogensHumansMagnetic Resonance SpectroscopyThermodynamicsAmmoniaAntineoplastic AgentsChloridesCisplatinHalogensIodidesOrganoplatinum Compoundscancercisplatin analogDFTNMRplatinum complexes
Identifiers
PMID41465564
PMCPMC12733153
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390